1. Nagano T, Lubling Y, Stevens TJ, Schoenfelder S, Yaffe E, Dean W,
et al. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. Nature 2013;502:59–64.
2. de Wit E, Bouwman BA, Zhu Y, Klous P, Splinter E, Verstegen MJ,
et al. The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature 2013;501:227–231.
3. Schoenfelder S, Sexton T, Chakalova L, Cope NF, Horton A, Andrews S,
et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat Genet 2010;42:53–61.
5. de Wit E, Vos ES, Holwerda SJ, Valdes-Quezada C, Verstegen MJ, Teunissen H,
et al. CTCF binding polarity determines chromatin looping. Mol Cell 2015;60:676–684.
6. Phillips-Cremins JE, Sauria ME, Sanyal A, Gerasimova TI, Lajoie BR, Bell JS,
et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 2013;153:1281–1295.
8. Merkenschlager M, Nora EP. CTCF and cohesin in genome folding and transcriptional gene regulation. Annu Rev Genomics Hum Genet 2016;17:17–43.
11. Mehta GD, Kumar R, Srivastava S, Ghosh SK. Cohesin: functions beyond sister chromatid cohesion. FEBS Lett 2013;587:2299–2312.
12. Yan J, Enge M, Whitington T, Dave K, Liu J, Sur I,
et al. Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites. Cell 2013;154:801–813.
13. Seitan VC, Faure AJ, Zhan Y, McCord RP, Lajoie BR, Ing-Simmons E,
et al. Cohesin-based chromatin interactions enable regulated gene expression within preexisting architectural compartments. Genome Res 2013;23:2066–2077.
14. Schaaf CA, Kwak H, Koenig A, Misulovin Z, Gohara DW, Watson A,
et al. Genome-wide control of RNA polymerase II activity by cohesin. PLoS Genet 2013;9:e1003382.
15. Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y,
et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012;485:376–380.
16. Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N,
et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 2012;485:381–385.
18. Wijchers PJ, de Laat W. Genome organization influences partner selection for chromosomal rearrangements. Trends Genet 2011;27:63–71.
20. Osborne CS, Chakalova L, Mitchell JA, Horton A, Wood AL, Bolland DJ,
et al. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol 2007;5:e192.
23. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J,
et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010;463:899–905.
24. Alabert C, Groth A. Chromatin replication and epigenome maintenance. Nat Rev Mol Cell Biol 2012;13:153–167.
25. Albertson DG. Gene amplification in cancer. Trends Genet 2006;22:447–455.
26. Hsu PY, Hsu HK, Lan X, Juan L, Yan PS, Labanowska J,
et al. Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. Cancer Cell 2013;24:197–212.
28. Zhang Y, McCord RP, Ho YJ, Lajoie BR, Hildebrand DG, Simon AC,
et al. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 2012;148:908–921.
29. Awad TA, Bigler J, Ulmer JE, Hu YJ, Moore JM, Lutz M,
et al. Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J Biol Chem 1999;274:27092–27098.
30. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 1999;98:387–396.
31. Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A,
et al. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000;10:853–856.
33. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB,
et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008;133:1106–1117.
34. Bulger M, Schübeler D, Bender MA, Hamilton J, Farrell CM, Hardison RC,
et al. A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus. Mol Cell Biol 2003;23:5234–5244.
38. Murrell A, Heeson S, Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 2004;36:889–893.
39. Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z,
et al. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci U S A 2006;103:10684–10689.
41. Degner SC, Verma-Gaur J, Wong TP, Bossen C, Iverson GM, Torkamani A,
et al. CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc Natl Acad Sci U S A 2011;108:9566–9571.
43. Wang H, Maurano MT, Qu H, Varley KE, Gertz J, Pauli F,
et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res 2012;22:1680–1688.
44. Wang XQ, Dostie J. Chromosome folding and its regulation in health and disease. Curr Opin Genet Dev 2017;43:23–30.
45. Rodriguez C, Borgel J, Court F, Cathala G, Forné T, Piette J. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus. Biochem Biophys Res Commun 2010;392:129–134.
47. Lai AY, Fatemi M, Dhasarathy A, Malone C, Sobol SE, Geigerman C,
et al. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. J Exp Med 2010;207:1939–1950.
48. Le May N, Fradin D, Iltis I, Bougnères P, Egly JM. XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genes. Mol Cell 2012;47:622–632.
49. Kang JY, Song SH, Yun J, Jeon MS, Kim HP, Han SW,
et al. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression. Oncogene 2015;34:5677–5684.
50. Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA,
et al.
CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 2011;471:235–239.
51. Dolnik A, Engelmann JC, Scharfenberger-Schmeer M, Mauch J, Kelkenberg-Schade S, Haldemann B,
et al. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Blood 2012;120:e83–e92.
52. Gregor A, Oti M, Kouwenhoven EN, Hoyer J, Sticht H, Ekici AB,
et al.
De novo mutations in the genome organizer CTCF cause intellectual disability. Am J Hum Genet 2013;93:124–131.
53. Katainen R, Dave K, Pitkänen E, Palin K, Kivioja T, Välimäki N,
et al. CTCF/cohesin-binding sites are frequently mutated in cancer. Nat Genet 2015;47:818–821.
55. Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S,
et al. 3D chromosome regulatory landscape of human pluripotent cells. Cell Stem Cell 2016;18:262–275.
56. Tang Z, Luo OJ, Li X, Zheng M, Zhu JJ, Szalaj P,
et al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell 2015;163:1611–1627.
57. Donohoe ME, Zhang LF, Xu N, Shi Y, Lee JT. Identification of a Ctcf cofactor, Yy1, for the X chromosome binary switch. Mol Cell 2007;25:43–56.
58. Ishihara K, Oshimura M, Nakao M. CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol Cell 2006;23:733–742.
59. Defossez PA, Kelly KF, Filion GJ, Pérez-Torrado R, Magdinier F, Menoni H,
et al. The human enhancer blocker CTC-binding factor interacts with the transcription factor Kaiso. J Biol Chem 2005;280:43017–43023.
61. Parelho V, Hadjur S, Spivakov M, Leleu M, Sauer S, Gregson HC,
et al. Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 2008;132:422–433.
62. Rubio ED, Reiss DJ, Welcsh PL, Disteche CM, Filippova GN, Baliga NS,
et al. CTCF physically links cohesin to chromatin. Proc Natl Acad Sci U S A 2008;105:8309–8314.
64. Nasmyth K, Haering CH. Cohesin: its roles and mechanisms. Annu Rev Genet 2009;43:525–558.
65. Merkenschlager M, Odom DT. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 2013;152:1285–1297.
67. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S,
et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008;134:521–533.
68. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D,
et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A 2008;105:3443–3448.
69. Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ,
et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059–2074.
70. Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y,
et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet 2013;45:1232–1237.
71. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT,
et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 2011;333:1039–1043.
73. Wendt KS, Yoshida K, Itoh T, Bando M, Koch B, Schirghuber E,
et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008;451:796–801.
74. Nativio R, Wendt KS, Ito Y, Huddleston JE, Uribe-Lewis S, Woodfine K,
et al. Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus. PLoS Genet 2009;5:e1000739.
75. Hadjur S, Williams LM, Ryan NK, Cobb BS, Sexton T, Fraser P,
et al. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 2009;460:410–413.
77. Ribeiro de Almeida C, Stadhouders R, de Bruijn MJ, Bergen IM, Thongjuea S, Lenhard B,
et al. The DNA-binding protein CTCF limits proximal Vkappa recombination and restricts kappa enhancer interactions to the immunoglobulin kappa light chain locus. Immunity 2011;35:501–513.
78. Seitan VC, Hao B, Tachibana-Konwalski K, Lavagnolli T, Mira-Bontenbal H, Brown KE,
et al. A role for cohesin in T-cell-receptor rearrangement and thymocyte differentiation. Nature 2011;476:467–471.
79. Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R,
et al. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of
de novo methylation upon maternal inheritance. Mol Cell Biol 2004;24:3497–3504.
80. Ling JQ, Li T, Hu JF, Vu TH, Chen HL, Qiu XW,
et al. CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 2006;312:269–272.
82. Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT,
et al. A 3D map of the human genome at kilo-base resolution reveals principles of chromatin looping. Cell 2014;159:1665–1680.
83. Guo Y, Xu Q, Canzio D, Shou J, Li J, Gorkin DU,
et al. CRISPR inversion of CTCF sites alters genome topology and enhancer/promoter function. Cell 2015;162:900–910.
84. Canela A, Maman Y, Jung S, Wong N, Callen E, Day A,
et al. Genome organization drives chromosome fragility. Cell 2017;170:507–521.e518.
85. Yun J, Song SH, Kang JY, Park J, Kim HP, Han SW,
et al. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability. Nucleic Acids Res 2016;44:558–572.
86. Deardorff MA, Wilde JJ, Albrecht M, Dickinson E, Tennstedt S, Braunholz D,
et al. RAD21 mutations cause a human cohesinopathy. Am J Hum Genet 2012;90:1014–1027.
88. Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO,
et al. Insulator dysfunction and oncogene activation in
IDH mutant gliomas. Nature 2016;529:110–114.
89. Hnisz D, Weintraub AS, Day DS, Valton AL, Bak RO, Li CH,
et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science 2016;351:1454–1458.
90. Lupianez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E,
et al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 2015;161:1012–1025.
91. Pott S, Lieb JD. What are super-enhancers? Nat Genet 2015;47:8–12.
92. Amabile A, Migliara A, Capasso P, Biffi M, Cittaro D, Naldini L,
et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 2016;167:219–232.e214.
93. Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S,
et al. Editing DNA methylation in the mammalian genome. Cell 2016;167:233–247.e217.
94. Simeonov DR, Gowen BG, Boontanrart M, Roth TL, Gagnon JD, Mumbach MR,
et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 2017;549:111–115.